ID: h-debate-0cf134d5d9b8
Hypothesis

Selective Microglial Senescence Targeting via P16INK4A-Guided Senolytics

Using P16INK4A-targeting nanoparticles loaded with dasatinib+quercetin to selectively eliminate senescent microglia.
🧬 CDKN2A, BCL2L1, BCL2🎯 Composite 0%💱 $0.51▲1.5%proposed
neurodegeneration
EvidenceModerate (50%)📖 0 cit🗣 1 debates 5 support 0 oppose
✓ All Quality Gates Passed

🧪 Overview

Using P16INK4A-targeting nanoparticles loaded with dasatinib+quercetin to selectively eliminate senescent microglia

Debate provenance: derived from debate `sess_SDA-2026-04-02-gap-senescent-clearance-neuro` on question: Senescent cell clearance as neurodegeneration therapy. Consensus signal: domain_expert, skeptic, synthesizer, theorist discussed the mechanism terms BCL2, BCL2L1, CDKN2A, Microglial, P16INK4A, P16INK4A-Guided, Selective, Senescence. Novelty signal: skeptic-discussed-with-qualified-concession.

🧬 Mechanism

🔗 Mechanism from KG for CDKN2A, BCL2L1, BCL2

Auto-built from this analysis's top knowledge-graph edges.

graph TD
    CDKN2A["CDKN2A"] -->|encodes| p16INK4A["p16INK4A"]
    p16INK4A_1["p16INK4A"] -->|regulates| Cellular_senescence["Cellular senescence"]
    CELLULAR_SENESCENCE["CELLULAR_SENESCENCE"] -->|causes| neuroinflammation["neuroinflammation"]
    Tau_protein["Tau protein"] -->|mediates| Tau_Propagation["Tau Propagation"]
    Tau_Propagation_2["Tau Propagation"] -->|causes| Alzheimer_disease["Alzheimer disease"]
    CELLULAR_SENESCENCE_3["CELLULAR_SENESCENCE"] -->|activates| Tau_Propagation_4["Tau Propagation"]
    senescent_neurons["senescent neurons"] -->|causes| Tau_Propagation_5["Tau Propagation"]
    senescent_microglia["senescent microglia"] -->|causes| neuroinflammation_6["neuroinflammation"]
    SASP["SASP"] -->|associated with| neuroinflammation_7["neuroinflammation"]
    MTOR["MTOR"] -->|regulates| SASP_8["SASP"]
    RELA["RELA"] -->|regulates| neuroinflammation_9["neuroinflammation"]
    p16INK4A_10["p16INK4A"] -->|biomarker for| senescent_microglia_11["senescent microglia"]
    style CDKN2A fill:#ce93d8,stroke:#333,color:#000
    style p16INK4A fill:#4fc3f7,stroke:#333,color:#000
    style p16INK4A_1 fill:#4fc3f7,stroke:#333,color:#000
    style Cellular_senescence fill:#4fc3f7,stroke:#333,color:#000
    style CELLULAR_SENESCENCE fill:#4fc3f7,stroke:#333,color:#000
    style neuroinflammation fill:#4fc3f7,stroke:#333,color:#000
    style Tau_protein fill:#4fc3f7,stroke:#333,color:#000
    style Tau_Propagation fill:#4fc3f7,stroke:#333,color:#000
    style Tau_Propagation_2 fill:#4fc3f7,stroke:#333,color:#000
    style Alzheimer_disease fill:#ef5350,stroke:#333,color:#000
    style CELLULAR_SENESCENCE_3 fill:#4fc3f7,stroke:#333,color:#000
    style Tau_Propagation_4 fill:#4fc3f7,stroke:#333,color:#000
    style senescent_neurons fill:#4fc3f7,stroke:#333,color:#000
    style Tau_Propagation_5 fill:#4fc3f7,stroke:#333,color:#000
    style senescent_microglia fill:#4fc3f7,stroke:#333,color:#000
    style neuroinflammation_6 fill:#4fc3f7,stroke:#333,color:#000
    style SASP fill:#4fc3f7,stroke:#333,color:#000
    style neuroinflammation_7 fill:#4fc3f7,stroke:#333,color:#000
    style MTOR fill:#ce93d8,stroke:#333,color:#000
    style SASP_8 fill:#4fc3f7,stroke:#333,color:#000
    style RELA fill:#ce93d8,stroke:#333,color:#000
    style neuroinflammation_9 fill:#4fc3f7,stroke:#333,color:#000
    style p16INK4A_10 fill:#4fc3f7,stroke:#333,color:#000
    style senescent_microglia_11 fill:#4fc3f7,stroke:#333,color:#000

⚖️ Evidence

⚖️ Evidence Matrix4 supports0 contradicts
Supports
Evidence from: Engineered Exosome-Based Senolytic Therapy Alleviates Stroke by Targeting p21(+)CD86(+) Microglia.
Exploration (Beijing)2025medium
Supports
Evidence from: The senescent niche hypothesis: microglial dysfunction and replacement strategies in drug-resistant epilepsy.
Front Immunol2026medium
Supports
Evidence from: Senescent and disease-associated microglia are modifiable features of aged brain white matter.
Res Sq2023medium
Supports
Evidence from: Inflammation and aging: signaling pathways and intervention therapies
Signal Transduction and Targeted Therapy2023medium
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — CDKN2A

No curated PDB or AlphaFold mapping for CDKN2A yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for CDKN2A, BCL2L1, BCL2 →

No DepMap CRISPR Chronos data found for CDKN2A, BCL2L1, BCL2.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0002
Events (7d)
1
Price History
▲1.5%

💾 Resource Usage

LLM Tokens
14,792
$0.0888
Total Cost
$0.0888
Metadatasource: v1_phase_c_backfill · origin_type: debate_round_mining
sourcev1_phase_c_backfill
origin_typedebate_round_mining
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.